Validation of biocides against duck hepatitis B virus as a surrogate virus for human hepatitis B virus.
The use of a surrogate virus, namely duck hepatitis B virus (DHBV), has been recommended for testing the virucidal activity of chemical biocides against hepatitis B virus. To date, however, this model has not been recognized as a standard test in European countries, as its laboratory use is associated with considerable difficulties. As previous studies have demonstrated, several alternative procedures may improve the validation of DHBV infection in a cell culture system. Using indirect immunofluorescent antigen staining and the light cycler real-time polymerase chain reaction (PCR) technique, the virucidal activity of peracetic acid (PAA), povidone-iodine (PVP-I) and formaldehyde was tested against DHBV obtained from congenitally infected ducks or prepared from the transfected hepatoma D2 cell line. The results demonstrated that inactivation of DHBV from the D2 cell line was achieved with lower concentrations of the biocides and within shorter exposure time intervals. These lower concentration-exposure time values for DHBV from D2 cells in comparison with DHBV from infected ducks indicated a higher sensitivity of the virus derived from D2 cells. In addition, concentrations of PAA and PVP-I that significantly inactivated DHBV in suspension tests were not able to destroy the viral genome. In conclusion, DHBV from congenitally infected ducks should be used for virucidal testing of chemical biocides against DHBV; DHBV prepared from D2 cells is unsuitable due to its higher sensitivity to biocides. Indirect immunofluorescent staining allows reliable detection of DHBV infectivity, whereas the hepadnavirucidal effect can be evaluated by quantitative PCR.
Sauerbrei
A
A
Institute of Virology and Antiviral Therapy, Friedrich-Schiller University, Jena, Germany. Andreas.Sauerbrei@med.uni-jena.de
Schacke
M
M
Glück
B
B
Egerer
R
R
Wutzler
P
P
D000818:Animals; D002478:Cells, Cultured; D004202:Disinfectants / Q000494:pharmacology*; D004372:Ducks; D005455:Fluorescent Antibody Technique; D005557:Formaldehyde / Q000494:pharmacology*; D015611:Hepatitis B Virus, Duck / Q000187:drug effects* / Q000472:pathogenicity; D006515:Hepatitis B virus / Q000187:drug effects; D006801:Humans; D017053:Infection Control / Q000379:methods / Q000592:standards; D036341:Intercellular Signaling Peptides and Proteins; D008826:Microbial Sensitivity Tests; D023421:Models, Animal; D009942:Organometallic Compounds; D010455:Peptides; D010463:Peracetic Acid / Q000494:pharmacology*; D011206:Povidone-Iodine / Q000494:pharmacology*
D004202:Disinfectants; D036341:Intercellular Signaling Peptides and Proteins; D009942:Organometallic Compounds; C074094:PC 1038; D010455:Peptides; D005557:Formaldehyde; D011206:Povidone-Iodine; D010463:Peracetic Acid